Patheon has signed agreements to commercialize two controlled release products utilizing OROS technology from its Cincinnati facility. The first product will launch in late 2009 and the second is planned to launch in 3Q10.

OROS is a specialized drug delivery technology used for the controlled release of active drug substances. The company developed the technology in collaboration with clients and an equipment manufacturer and has designated the Cincinnati facility as the Center of Excellence for controlled release technologies.

Terry Novak, president of North America and chief commercial officer, stated, “This process is very unique and requires special equipment and expertise to successfully develop and commercialize OROS-based products. Having the development and commercial expertise available at our Cincinnati facility allows our customers to quickly and successfully launch OROS-based products and extend the life cycle of their products.”